INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells

Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2012-04, Vol.72 (8), p.2006-2016
Hauptverfasser: MORRIS, Christelle, TOMIMATSU, Nozomi, RICHARD, Derek J, CLUET, David, BURMA, Sandeep, KUM KHANNA, Kum, JALINOT, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2016
container_issue 8
container_start_page 2006
container_title Cancer research (Chicago, Ill.)
container_volume 72
creator MORRIS, Christelle
TOMIMATSU, Nozomi
RICHARD, Derek J
CLUET, David
BURMA, Sandeep
KUM KHANNA, Kum
JALINOT, Pierre
description Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.
doi_str_mv 10.1158/0008-5472.CAN-11-2562
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3335344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020842813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</originalsourceid><addsrcrecordid>eNpdkV1v0zAUhi0EYmXwE0C-QZqQsvkzcW6Qoq5bI5UyTeXact2TNSixOzsZ8O9x1a58XFnn-Hnf4-MXofeUXFIq1RUhRGVSFOxyWi0zSjMmc_YCTajkKiuEkC_R5MScoTcxfk-lpES-RmeMSaLyspigrl6u8qtZfcNnuHYDBGOHiH-0wxZXqy_YuA2uI76Hx7ENsMGND_gu-B0EPPsJdhxa77Bv8LAFfL2s8LXpzQMkPu68i4Bbh-djbxyeQtfFt-hVY7oI747nOfp2M1tN59ni6209rRaZlaQcMssNa1Re5JwIKUqa3i2UKDbCCtbIdWpZI4WBUqWqYcCVkoLmTVkCF-uc8HP0-eC7G9c9bCy4IZhO70Lbm_BLe9Pqf29cu9UP_klzziUXIhl8Ohhs_5PNq4UGFzudfpYUBRNPNMEXx2nBP44QB9230aZ9jQM_Rk0JI0owRXlC5QG1wccYoDmZU6L3sep9ZHofmU6xppbex5p0H_5e6KR6zjEBH4-AidZ0TTDOtvEPJxWlghT8N9qZp_M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020842813</pqid></control><display><type>article</type><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</creator><creatorcontrib>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</creatorcontrib><description>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-11-2562</identifier><identifier>PMID: 22508697</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Ataxia telangiectasia mutated protein ; Ataxia Telangiectasia Mutated Proteins ; Biological and medical sciences ; BRCA1 protein ; BRCA1 Protein - metabolism ; Breast cancer ; Cancer ; Carcinogenesis ; Cell Cycle Checkpoints ; Cell Cycle Proteins - metabolism ; Cell Line, Tumor ; Cell Survival ; Cell Transformation, Neoplastic - metabolism ; CHK1 protein ; DNA damage ; DNA Damage - physiology ; DNA repair ; DNA-Binding Proteins - metabolism ; Drugs ; Eukaryotic Initiation Factor-3 - metabolism ; Fluorescent Antibody Technique ; Gene Knockdown Techniques ; Humans ; Immunoblotting ; Immunoprecipitation ; Initiation factors ; INT6 gene ; Life Sciences ; Medical sciences ; Microscopy, Confocal ; Pharmacology. Drug treatments ; Phosphorylation ; Protein-Serine-Threonine Kinases - metabolism ; RNA ; RNA-mediated interference ; Translation ; Tumor Suppressor Proteins - metabolism ; Tumors ; Ubiquitin</subject><ispartof>Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2006-2016</ispartof><rights>2015 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</citedby><cites>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</cites><orcidid>0000-0002-9836-6849</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25811407$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22508697$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://ens-lyon.hal.science/ensl-00807724$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>MORRIS, Christelle</creatorcontrib><creatorcontrib>TOMIMATSU, Nozomi</creatorcontrib><creatorcontrib>RICHARD, Derek J</creatorcontrib><creatorcontrib>CLUET, David</creatorcontrib><creatorcontrib>BURMA, Sandeep</creatorcontrib><creatorcontrib>KUM KHANNA, Kum</creatorcontrib><creatorcontrib>JALINOT, Pierre</creatorcontrib><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</description><subject>Antineoplastic agents</subject><subject>Ataxia telangiectasia mutated protein</subject><subject>Ataxia Telangiectasia Mutated Proteins</subject><subject>Biological and medical sciences</subject><subject>BRCA1 protein</subject><subject>BRCA1 Protein - metabolism</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Cell Cycle Checkpoints</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>CHK1 protein</subject><subject>DNA damage</subject><subject>DNA Damage - physiology</subject><subject>DNA repair</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Drugs</subject><subject>Eukaryotic Initiation Factor-3 - metabolism</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Knockdown Techniques</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Immunoprecipitation</subject><subject>Initiation factors</subject><subject>INT6 gene</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Microscopy, Confocal</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>RNA</subject><subject>RNA-mediated interference</subject><subject>Translation</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Tumors</subject><subject>Ubiquitin</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1v0zAUhi0EYmXwE0C-QZqQsvkzcW6Qoq5bI5UyTeXact2TNSixOzsZ8O9x1a58XFnn-Hnf4-MXofeUXFIq1RUhRGVSFOxyWi0zSjMmc_YCTajkKiuEkC_R5MScoTcxfk-lpES-RmeMSaLyspigrl6u8qtZfcNnuHYDBGOHiH-0wxZXqy_YuA2uI76Hx7ENsMGND_gu-B0EPPsJdhxa77Bv8LAFfL2s8LXpzQMkPu68i4Bbh-djbxyeQtfFt-hVY7oI747nOfp2M1tN59ni6209rRaZlaQcMssNa1Re5JwIKUqa3i2UKDbCCtbIdWpZI4WBUqWqYcCVkoLmTVkCF-uc8HP0-eC7G9c9bCy4IZhO70Lbm_BLe9Pqf29cu9UP_klzziUXIhl8Ohhs_5PNq4UGFzudfpYUBRNPNMEXx2nBP44QB9230aZ9jQM_Rk0JI0owRXlC5QG1wccYoDmZU6L3sep9ZHofmU6xppbex5p0H_5e6KR6zjEBH4-AidZ0TTDOtvEPJxWlghT8N9qZp_M</recordid><startdate>20120415</startdate><enddate>20120415</enddate><creator>MORRIS, Christelle</creator><creator>TOMIMATSU, Nozomi</creator><creator>RICHARD, Derek J</creator><creator>CLUET, David</creator><creator>BURMA, Sandeep</creator><creator>KUM KHANNA, Kum</creator><creator>JALINOT, Pierre</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9836-6849</orcidid></search><sort><creationdate>20120415</creationdate><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><author>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antineoplastic agents</topic><topic>Ataxia telangiectasia mutated protein</topic><topic>Ataxia Telangiectasia Mutated Proteins</topic><topic>Biological and medical sciences</topic><topic>BRCA1 protein</topic><topic>BRCA1 Protein - metabolism</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Cell Cycle Checkpoints</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>CHK1 protein</topic><topic>DNA damage</topic><topic>DNA Damage - physiology</topic><topic>DNA repair</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Drugs</topic><topic>Eukaryotic Initiation Factor-3 - metabolism</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Knockdown Techniques</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Immunoprecipitation</topic><topic>Initiation factors</topic><topic>INT6 gene</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Microscopy, Confocal</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>RNA</topic><topic>RNA-mediated interference</topic><topic>Translation</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Tumors</topic><topic>Ubiquitin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MORRIS, Christelle</creatorcontrib><creatorcontrib>TOMIMATSU, Nozomi</creatorcontrib><creatorcontrib>RICHARD, Derek J</creatorcontrib><creatorcontrib>CLUET, David</creatorcontrib><creatorcontrib>BURMA, Sandeep</creatorcontrib><creatorcontrib>KUM KHANNA, Kum</creatorcontrib><creatorcontrib>JALINOT, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MORRIS, Christelle</au><au>TOMIMATSU, Nozomi</au><au>RICHARD, Derek J</au><au>CLUET, David</au><au>BURMA, Sandeep</au><au>KUM KHANNA, Kum</au><au>JALINOT, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2012-04-15</date><risdate>2012</risdate><volume>72</volume><issue>8</issue><spage>2006</spage><epage>2016</epage><pages>2006-2016</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>22508697</pmid><doi>10.1158/0008-5472.CAN-11-2562</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9836-6849</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2006-2016
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3335344
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Antineoplastic agents
Ataxia telangiectasia mutated protein
Ataxia Telangiectasia Mutated Proteins
Biological and medical sciences
BRCA1 protein
BRCA1 Protein - metabolism
Breast cancer
Cancer
Carcinogenesis
Cell Cycle Checkpoints
Cell Cycle Proteins - metabolism
Cell Line, Tumor
Cell Survival
Cell Transformation, Neoplastic - metabolism
CHK1 protein
DNA damage
DNA Damage - physiology
DNA repair
DNA-Binding Proteins - metabolism
Drugs
Eukaryotic Initiation Factor-3 - metabolism
Fluorescent Antibody Technique
Gene Knockdown Techniques
Humans
Immunoblotting
Immunoprecipitation
Initiation factors
INT6 gene
Life Sciences
Medical sciences
Microscopy, Confocal
Pharmacology. Drug treatments
Phosphorylation
Protein-Serine-Threonine Kinases - metabolism
RNA
RNA-mediated interference
Translation
Tumor Suppressor Proteins - metabolism
Tumors
Ubiquitin
title INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INT6/EIF3E%20Interacts%20with%20ATM%20and%20Is%20Required%20for%20Proper%20Execution%20of%20the%20DNA%20Damage%20Response%20in%20Human%20Cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=MORRIS,%20Christelle&rft.date=2012-04-15&rft.volume=72&rft.issue=8&rft.spage=2006&rft.epage=2016&rft.pages=2006-2016&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-11-2562&rft_dat=%3Cproquest_pubme%3E1020842813%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020842813&rft_id=info:pmid/22508697&rfr_iscdi=true